274 related articles for article (PubMed ID: 37083660)
1. Ingestion of Illicit Substances by Young Children Before and During the COVID-19 Pandemic.
Raffa BJ; Schilling S; Henry MK; Ritter V; Bennett CE; Huang JS; Laub N
JAMA Netw Open; 2023 Apr; 6(4):e239549. PubMed ID: 37083660
[TBL] [Abstract][Full Text] [Related]
2. Child Protection System Interactions for Children With Positive Urine Screens for Illicit Drugs.
Rebbe R; Malicki D; Siddiqi N; Huang JS; Putnam-Hornstein E; Laub N
JAMA Netw Open; 2024 Mar; 7(3):e243133. PubMed ID: 38512254
[TBL] [Abstract][Full Text] [Related]
3. Substance use during the COVID-19 pandemic: What is really happening?
Mellos E; Paparrigopoulos T
Psychiatriki; 2022 Mar; 33(1):17-20. PubMed ID: 35255473
[TBL] [Abstract][Full Text] [Related]
4. The Effect of COVID-19 Stay-At-Home Orders on the Rate of Pediatric Foreign Body Ingestions.
Neal JT; Monuteaux MC; Porter JJ; Hudgins JD
J Emerg Med; 2022 Dec; 63(6):729-737. PubMed ID: 36289021
[TBL] [Abstract][Full Text] [Related]
5. Changes in unintentional cannabis exposures in children 6 months to 5 years reported to United States poison centers during the first nine months of the coronavirus-19 pandemic.
Laudone TW; Leonard JB; Hines EQ; Seung H; Klein-Schwartz W
Clin Toxicol (Phila); 2022 Sep; 60(9):1029-1031. PubMed ID: 35471155
[TBL] [Abstract][Full Text] [Related]
6. Toxic Exposures Among Young Children One Year into the COVID-19 Pandemic: A Retrospective Review of Three San Francisco Bay Area Emergency Departments.
Devlin G; Addo N; Shaahinfar A; Chen CC; Grupp-Phelan J; Kornblith AE
J Emerg Med; 2023 Feb; 64(2):263-268. PubMed ID: 36828751
[TBL] [Abstract][Full Text] [Related]
7. Cannabis Legalization and Resource Use for Ingestions by Young Children.
Walsh PS; Dupont AS; Lipshaw MJ; Visotcky A; Thomas DG
Pediatrics; 2024 Jun; 153(6):. PubMed ID: 38690624
[TBL] [Abstract][Full Text] [Related]
8. Individual and Combined Association Between Prenatal Polysubstance Exposure and Childhood Risk of Attention-Deficit/Hyperactivity Disorder.
Garrison-Desany HM; Hong X; Maher BS; Beaty TH; Wang G; Pearson C; Liang L; Wang X; Ladd-Acosta C
JAMA Netw Open; 2022 Mar; 5(3):e221957. PubMed ID: 35275164
[TBL] [Abstract][Full Text] [Related]
9. An overview of the use of psychoactive substances among students at the University of Lille during the COVID-19 health crisis: Results of the PETRA study.
Carton L; Bastien A; Chérot N; Caron C; Deheul S; Cottencin O; Gautier S; Moreau-Crépeaux S; Dondaine T; Bordet R
Dialogues Clin Neurosci; 2023 Dec; 25(1):101-111. PubMed ID: 37837439
[TBL] [Abstract][Full Text] [Related]
10. Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada.
Myran DT; Roberts R; Pugliese M; Taljaard M; Tanuseputro P; Pacula RL
JAMA Netw Open; 2022 Sep; 5(9):e2231937. PubMed ID: 36112372
[TBL] [Abstract][Full Text] [Related]
11. Setting the baseline: a description of cannabis poisonings at a Canadian pediatric hospital prior to the legalization of recreational cannabis.
Cheng P; Zagaran A; Rajabali F; Turcotte K; Babul S
Health Promot Chronic Dis Prev Can; 2020 Jun; 40(5-6):193-200. PubMed ID: 32529979
[TBL] [Abstract][Full Text] [Related]
12. Hospital Admissions for Abusive Head Trauma Before and During the COVID-19 Pandemic.
Maassel NL; Graetz E; Schneider EB; Asnes AG; Solomon DG; Leventhal JM
JAMA Pediatr; 2023 Dec; 177(12):1342-1347. PubMed ID: 37870839
[TBL] [Abstract][Full Text] [Related]
13. Identification of cannabinoids in post-mortem blood samples from the province of New Brunswick before and after recreational cannabis legalization.
Jordan A; Sherazi A; Flewelling AJ; Northrup V; Naseemuddin A; Shea JL
Int J Drug Policy; 2022 May; 103():103629. PubMed ID: 35228057
[TBL] [Abstract][Full Text] [Related]
14. Changes in secondary substance use after the onset of the COVID-19 pandemic among people who use cannabis: Findings from a web-based sample of adults in the United States.
Lake S; Assaf RD; Gorbach PM; Cooper ZD
Exp Clin Psychopharmacol; 2023 Apr; 31(2):482-490. PubMed ID: 35467920
[TBL] [Abstract][Full Text] [Related]
15. Patterns of polysubstance use and clinical comorbidity among persons seeking substance use treatment: An observational study.
Ellis JD; Rabinowitz JA; Ware OD; Wells J; Dunn KE; Huhn AS
J Subst Use Addict Treat; 2023 Mar; 146():208932. PubMed ID: 36880895
[TBL] [Abstract][Full Text] [Related]
16. Pediatric surgery and future risk of cocaine, opioid, cannabis, and other substance use in women: longitudinal cohort study.
Auger N; Low N; Ayoub A; Lo E; Luu TM
Drug Alcohol Depend; 2021 Sep; 226():108902. PubMed ID: 34304123
[TBL] [Abstract][Full Text] [Related]
17. COVID-19-related flexibility in methadone take-home doses associated with decreased attrition: Report from an opioid treatment program in central Pennsylvania.
Kawasaki SS; Zimmerman R; Shen C; Zgierska AE
J Subst Use Addict Treat; 2023 Dec; 155():209164. PubMed ID: 37730014
[TBL] [Abstract][Full Text] [Related]
18. Do young children with known cannabis intoxication benefit from further neurological-based testing or imaging?
Dupont AS; Walsh PS
Am J Emerg Med; 2024 Jan; 75():119-121. PubMed ID: 37944295
[TBL] [Abstract][Full Text] [Related]
19. Hospital Variation in Child Protection Reports of Substance Exposed Infants.
Rebbe R; Mienko JA; Brown E; Rowhani-Rahbar A
J Pediatr; 2019 May; 208():141-147.e2. PubMed ID: 30770194
[TBL] [Abstract][Full Text] [Related]
20. Trends in Substance-Related Visits Among Youth to US Children's Hospitals, 2016-2021: An Analysis of the Pediatric Health Information System Database.
Ball A; Hadland S; Rodean J; Hall M; Mendoza J; Ahrens K
J Adolesc Health; 2024 Jul; 75(1):76-84. PubMed ID: 38530681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
